These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7517377)

  • 1. BPH: new guidelines based on symptoms and patient preference. The Agency for Health Care Policy and Research.
    Roberts RG
    Geriatrics; 1994 Jul; 49(7):24-31. PubMed ID: 7517377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia. New concepts in the 1990s.
    Moul JW
    Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia in older men.
    Gerber GS
    Clin Geriatr Med; 1998 May; 14(2):317-31. PubMed ID: 9536108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's best for your patient with BPH?
    Neal RH; Keister D
    J Fam Pract; 2009 May; 58(5):241-7. PubMed ID: 19442387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia: diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel. Agency for Health Care Policy and Research.
    Am Fam Physician; 1994 Apr; 49(5):1157-65. PubMed ID: 7512308
    [No Abstract]   [Full Text] [Related]  

  • 12. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia.
    Jonler M; Riehmann M; Brinkmann R; Bruskewitz RC
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):795-807. PubMed ID: 7535688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for benign prostatic hyperplasia in older men.
    Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
    Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urologic diseases in America project: benign prostatic hyperplasia.
    Wei JT; Calhoun E; Jacobsen SJ
    J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What will replace TURP?
    Brawer MK; McConnell JD; Oesterling JE
    Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment of BPH.
    Roylance P; Gibelin B; Espié J
    Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPH: costs and treatment outcomes.
    Nickel JC
    Am J Manag Care; 2006 Apr; 12(5 Suppl):S141-8. PubMed ID: 16613528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.